A pharmacy on almost every busy Brazilian corner is probably one of these. Raia Drogasil, now branded RD Saúde, sells medicines and beauty products through the country's largest drugstore chain. Full nameRaia Drogasil S.A. (brand: RD Saúde) Tickers / exchangeRADL3, B3 (São Paulo); RADLY (US over-the-counter) HeadquartersSão Paulo, Brazil SectorHealthcare — pharmacy retail Employees75,190 Market value (market cap)R$28.41bn (US$5.52bn) Yearly sales (revenue, 2025)R$44.25bn (US$8.59bn) Net profit (2025)R$1.30bn (US$252m) Net margin2.84% (about 3 cents kept per real of sales) Return on equity18.9% Price-to-earnings20.8× Dividend yield2.0% Websiterdsaude.com.br What it is RD Saúde …
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Latest coverage
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →